A trial carried out in Europe suggests that repaglinide tablets are as effective and protected as insulin in treating individuals with newly diagnosed cystic-fibrosis-related diabetes (CFRD). Diabetes may result from the genetic situation cystic fibrosis if the pancreas turns into scarred...